The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b study of safety and immune response to PVX-410 vaccine alone and in combination with durvalumab (MEDI4736) in HLA-A2+ patients following adjuvant therapy for stage 2/3 triple negative breast cancer.
 
Steven J. Isakoff
Consulting or Advisory Role - Abbvie; Merrimack; Myriad Genetics; PharmaMar
Research Funding - Abbvie; Genentech; OncoPep; PharmaMar
Travel, Accommodations, Expenses - Myriad Genetics
 
Sara M. Tolaney
Research Funding - Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Nadine M. Tung
Research Funding - Myriad Genetics
Patents, Royalties, Other Intellectual Property - Ambry Genetics (Inst)
 
Sylvia Adams
No Relationships to Disclose
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; bioTheranostics; Celgene
Research Funding - Amgen (Inst); Genentech/Roche (Inst)
 
Elena F Brachtel
Research Funding - bioTheranostics (Inst)
Expert Testimony - Adler, Cohen, Harvey, Wakeman, Guekguezian, LLP
 
Karleen R. Habin
No Relationships to Disclose
 
Louisa J Bauer
No Relationships to Disclose
 
Leif W. Ellisen
Honoraria - Invitae
Consulting or Advisory Role - Vertex
Travel, Accommodations, Expenses - Invitae
 
Mariano Severgnini
No Relationships to Disclose
 
William Thomas Barry
Consulting or Advisory Role - ARMO BioSciences
Research Funding - Pfizer (Inst)
 
Doris Peterkin
Employment - OncoPep
Leadership - OncoPep
Stock and Other Ownership Interests - OncoPep